Literature DB >> 20012609

Left heart pump-assisted myocardial revascularization favorably affects neutrophil apoptosis.

Paolo Stassano1, Luigi Di Tommaso, Mario Monaco, Generoso Mastrogiovanni, Antonino Musumeci, Antonio Contaldo, Paolo Pepino.   

Abstract

OBJECTIVES: Granulocyte apoptosis is a key control process in the clearance of neutrophils from inflammatory sites, and its rate is modulated by a number of inflammatory mediators. In this study, we investigated whether the use of left ventricular-assisted technique (LVA) in beating heart myocardial revascularization would exert less impact on neutrophil apoptosis compared with conventional cardiopulmonary bypass (CPB).
METHODS: Forty consecutive patients who underwent myocardial revascularization were randomly assigned to LVA (group A, 21 patients) or CPB (group B, 19 patients). Blood samples for detection of interleukin-6, interleukin-8, and tumor necrosis factor-alpha were measured at baseline and at various time points postoperatively. Neutrophil apoptosis was detected by light microscopy as well as by the annexin-V assays together with the activity of caspase 3 on postoperative samples.
RESULTS: Preoperative clinical and demographic data did not differ between the two groups. The two groups also were similar with respect to mortality, number of grafts performed, duration of extracorporeal circulation, and need for inotropes. However postoperatively, spontaneous apoptosis was significantly delayed in neutrophils from CPB patients compared with LVA patients. Neutrophils were activated, as indicated by increased surface expression of CD11b. Caspase 3 activity was found to be significantly reduced in neutrophils from CPB patients after 18 and 24 hours of culture.
CONCLUSIONS: Patients who underwent beating heart myocardial revascularization with LVA show a better preserved neutrophil apoptosis than patients treated with the CPB.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20012609     DOI: 10.1007/s00268-009-0321-y

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  16 in total

Review 1.  Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update.

Authors:  D Paparella; T M Yau; E Young
Journal:  Eur J Cardiothorac Surg       Date:  2002-02       Impact factor: 4.191

2.  Role of apoptosis in myocardial stunning after open heart surgery.

Authors:  Joachim P Schmitt; Josef Schröder; Heribert Schunkert; Dietrich E Birnbaum; Hermann Aebert
Journal:  Ann Thorac Surg       Date:  2002-04       Impact factor: 4.330

3.  Extending myocardial viability during heart preservation with cyclosporine A.

Authors:  T N Masters; A A Fokin; J Schaper; S Lorenz-Meyer; L Pool; G Gong; F Robicsek
Journal:  J Card Surg       Date:  2000 Nov-Dec       Impact factor: 1.620

4.  Cytokine responses and myocardial injury in coronary artery bypass grafting.

Authors:  M Wei; P Kuukasjarvi; J Laurikka; S Kaukinen; P Iisalo; S Laine; P Laippala; R Metsänoja; M Tarkka
Journal:  Scand J Clin Lab Invest       Date:  2001-04       Impact factor: 1.713

5.  Relation of the -174 G/C polymorphism of interleukin-6 to interleukin-6 plasma levels and to length of hospitalization after surgical coronary revascularization.

Authors:  F Burzotta; L Iacoviello; A Di Castelnuovo; F Glieca; N Luciani; R Zamparelli; R Schiavello; M B Donati; A Maseri; G Possati; F Andreotti
Journal:  Am J Cardiol       Date:  2001-11-15       Impact factor: 2.778

6.  Inhibition of neutrophil apoptosis after coronary bypass operation with cardiopulmonary bypass.

Authors:  Massimo Chello; Pasquale Mastroroberto; Angela Quirino; Giovanni Cuda; Francesco Perticone; Francesco Cirillo; Elvio Covino
Journal:  Ann Thorac Surg       Date:  2002-01       Impact factor: 4.330

7.  Effects of on- and off-pump coronary artery surgery on graft patency, survival, and health-related quality of life: long-term follow-up of 2 randomized controlled trials.

Authors:  Gianni D Angelini; Lucy Culliford; David K Smith; Mark C K Hamilton; Gavin J Murphy; Raimondo Ascione; Andreas Baumbach; Barnaby C Reeves
Journal:  J Thorac Cardiovasc Surg       Date:  2009-02       Impact factor: 5.209

8.  Myocardial revascularization by left ventricular assisted beating heart is associated with reduced systemic inflammatory response.

Authors:  Paolo Stassano; Luigi Di Tommaso; Mario Monaco; Severino Iesu; Giancarlo Brando; Salvatore Buonpane; Giuseppe Ambrosio; Giuseppe Di Benedetto; Paolo Pepino
Journal:  Ann Thorac Surg       Date:  2009-01       Impact factor: 4.330

9.  Acute renal dysfunction after cardiac surgery with cardiopulmonary bypass is associated with plasmatic IL6 increase.

Authors:  Gildas Gueret; Francois Lion; Nathalie Guriec; Josiane Arvieux; Annabelle Dovergne; Catherine Guennegan; Eric Bezon; Raoul Baron; Jean-Luc Carre; Charles Arvieux
Journal:  Cytokine       Date:  2009-01-06       Impact factor: 3.861

10.  Inhibition of neutrophil adhesion during cardiopulmonary bypass.

Authors:  A M Gillinov; J M Redmond; K J Zehr; I C Wilson; W E Curtis; J M Bator; R M Burch; B A Reitz; W A Baumgartner; A Herskowitz
Journal:  Ann Thorac Surg       Date:  1994-01       Impact factor: 4.330

View more
  3 in total

Review 1.  Attenuating the Systemic Inflammatory Response to Adult Cardiopulmonary Bypass: A Critical Review of the Evidence Base.

Authors:  R Clive Landis; Jeremiah R Brown; David Fitzgerald; Donald S Likosky; Linda Shore-Lesserson; Robert A Baker; John W Hammon
Journal:  J Extra Corpor Technol       Date:  2014-09

2.  Protective Effects of Acupuncture in Cardiopulmonary Bypass-Induced Lung Injury in Rats.

Authors:  Wen Ma; Zigang Li; Zhou Lu; Wenling Tan; Zhewen Zhang; Yajun Li; Zhongwei Yang; Jia Zhou; Huifang Tang; Huashun Cui
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

Review 3.  Non-compliance with randomised allocation and missing outcome data in randomised controlled trials evaluating surgical interventions: a systematic review.

Authors:  Temitope E Adewuyi; Graeme MacLennan; Jonathan A Cook
Journal:  BMC Res Notes       Date:  2015-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.